A pooled analysis of the resistance patterns of escherichia coli strains isolated from urine cultures in turkey: A comparison of the periods 1997-2001 and 2002-2007;Türkiye'de idrar kültürlerinden izole edilen escherichia coli kökenlerinde direnç durumlarının havuz analizi: 1997-2001 ve 2002-2007 dönemlerinin karşılaştırılması

Turkish Journal of Medical Sciences

Volumn 41, Issue 3, 2011, Pages 557-564

  Taşbakan, Meltem Işikgöz ^a   Pullukçu, Hüsnü ^a   Sipahi, Oǧuz Reşat ^a   Yamazhan, Tansu ^a   Arda, Bilgin ^a   Ulusoy, Sercan ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

E. coli; Turkey; Urinary tract infections

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; NETILMICIN; NITROFURANTOIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; COMPARATIVE STUDY; CONTROLLED STUDY; ESCHERICHIA COLI; NONHUMAN; TURKEY (REPUBLIC);

EID: 79955551294     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: 10.3906/sag-1006-893     Document Type: Article

References (77)

1. Karaca Y, Coplu N, Gozalan A, Oncul O, Citil B, Esen B. Co-trimoxazole and quinolone resistance in Escherichia coli isolated from urinary tract infections over the last 10 years. Int J Antimicrob Agents 2005; 26: 75-7.
2. Arslan H, Azap KO, Ergonul O, Timurkaynak F. Risk factors for ciprofl oxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J Antimicrob Chemother 2005; 56: 914-8.
3. Pullukcu H, Tasbakan MI, Aydemir Ş, Sipahi OR, Turhan A, Ozinel MA et al. Th e bacteria isolated from urine cultures and their in- vitro antibiotic susceptibility. ANKEM Derg 2006; 20: 26-30.
4. Sturenburg E and Mack D. Extended spectrum beta-lactamases. Implications for the clinical microbiology laboratory, therapy and infection control. J Infect 2003; 47: 273-95.
5. Pullukcu, H, Aydemir S, Tasbakan MI, Cilli F, Tunger A, Ulusoy S. Susceptibility of extended-spectrum beta-lactamase producing Escherichia coli urine isolates to fosfomycin, ciprofl oxacin, amikacin and trimethoprim sulfamethoxazole. Turk J Med Sci 2008; 38: 175-180.
6. Yuksel S, Ozturk B, Kavaz A, Ozcakar ZB, Acar B, Guriz H et al. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections. Int J Antimicrob Agents 2006; 28: 413-6.
7. Clinical and Laboratory Standards Institute/NCCLS: Performance Standards for Antimicrobial Susceptibility Testing. 15. Informational Supplement, CLSI/NCCLS,M100-S15, Wayne: PA; 2005.
8. Yuluǧkural Z, Mutlu B. Susceptibility of Escherichia coli strains isolated from urine cultures to some commonly used antibacterial agents Medical Journal of Trakya University 2007; 24: 6-11.
9. Yilmaz E, Ozakin C, Sinirtaş M, Gedikoǧlu S. Microorganisms isolated from urine specimens in the bacteriology laboratory, Uludaǧ University Hospital, between 1999 and 2002. Turkish Journal of Infection 2005; 19: 91-96.
10. Ertuǧrul MB, Colak N. Antibiotic susceptibility rates of community-acquired uropathogenic Escherichia coli isolates. ANKEM Derg 2004; 18: 161-5.
11. Taşbakan MI, Pullukcu H, Yamazhan T, Arda B, Ulusoy S. Comparison of in-vitro activity of fosfomycin and other antibacterials in Escherichia coli strains isolated from community acquired urinary tract infections. ANKEM Derg 2004; 18: 216-219.
12. Bayraktar B, Ozcan N, Borahan S, Başari F, Bulut E. Resistance in Gram negative bacilli isolated from urinary tract infections in hospitalized and policlinic patients ANKEM Derg 2004; 18: 137-140.
13. Saracli MA, Baylan O, Gun H. Gram negative bacilli causing urinary tract infections and their antibiotic susceptibilities. ANKEM Derg 1999; 13: 73-78.
14. Kaygusuz S, Apan TZ, Kilic D. Resistance to various antibiotics of Gram-negative bacteria isolated from community-acquired urinary tract infections. ANKEM Derg 2001; 15: 753-9.
15. Erden S, Calangu S. Poliklinik hastalari{dotless}nda uriner sistem infeksiyonlari{dotless}ndan izole edilen Escherichia coli suşlari{dotless}ni{dotless}n ceşitli antibiyotiklere in vitro duyarli{dotless}li{dotless}klari{dotless}. Ist Ti{dotless}p Fak Mecmuasi{dotless} 2002; 65: 147-149.
16. Ozden M, Kalkan A, Demirdaǧ K, Kilic SS, Ozdarendereli A. Ciprofl oxacin and co-trimoxazole resistance in Escherichia coli strains isolated from urinary tract infections. ANKEM Derg 2003; 17: 51-55.
17. Aǧel E, Durmaz B, Kutlu O, Balat A, Aşgin N. Antimicrobial activity of loracarbef and its effi ciency in pediatric patients with urinary tract infections. ANKEM Derg 2000; 14: 79-84.
18. Cesur S, Albayrak F, Ozdemir D, Kolcu Z, Tekeli E. Antibiotic susceptibilities of Gram negative roads isolated from urine samples obtained from hospitalized patients. Turk Mikrobiyol Cem Derg 2002; 33: 174-6.
19. Demirturk N, Demirdal T, Eldemir H, Ince R, Altindiş M. Bacteria isolated from urine samples and their antibiotic susceptibilities. Turk Mikrobiyol Cem Derg 2005; 35: 103-6.
20. Kurutepe S, Surucuoǧlu S, Sezgin C, Gazi H, Gulay M, Ozbakkaloǧlu B. Increasing antimicrobial resistance in Escherichia coli isolated from community-acquired urinary tract infections during 1998-2003 in Manisa, Turkey. Jpn J Infect Dis 2005; 58: 159-161.
21. Otaǧ F, Yildiz C, Delialioǧlu N. Antibiotic resistance of Escherichia coli strains isolated from urine samples. ANKEM Derg 2003; 17: 384-387.
22. Baykan M, Kaya M, Arslan U, Baysal B. Sensitivity of antimicrobics to E. coli strains isolated from urine samples. Inonu Universitesi Ti{dotless}p Fakultesi Dergisi 2001; 8: 15-17.
23. Aydos SE, Yavuzdemir Ş, Nohutcu Y, Cavuş I. In vitro sensitivity of bacteria to various antibiotics, obtained from women suff ering from cystitis. Turk Jinekoloji ve Obstetrik Derneǧi Dergisi 2006; 3: 118-121.
24. Ozkalp B, Topcu A. Th e Gram negative bacteria those isolated from urinary tract infections and their susceptibility to various antibiotics. Selcuk Universitesi Ti{dotless}p Fakultesi Dergisi 2000; 16: 171-4.
25. Cetin H, Oktem F, Ormeci AR, Yorgancigil B, Yayli G. Escherichia coli and antibiotic resistance in childhood urinary tract infections. Suleyman Demirel Univeristesi Ti{dotless}p Fak Derg 2006; 13: 12-6.
26. Inan UN, Gurler N. Investigation of antibiotic resistance and some virulence factors of Escherichia coli strains isolated from children with urinary tract infections. ANKEM Derg 2004; 18: 89-96.
27. Gurgoze MK, Doǧan Y, Kizirgil A, Toraman ZA, Aygun D. Antibiotic sensitivities of bacteria isolated from children with urinary tract infections. Fi{dotless}rat Ti{dotless}p Dergisi 2002; 7: 828-832.
28. Gunduz T, Mumcuoǧlu I. Antimicrobial susceptibility of Escherichia coli strains isolated from urine samples. Turk Mikrobiyol Cem Derg 2004; 34: 157-161.
29. Elaldi N, Turan M, Duran B, Bakir M, Dokmetaş I, Bakici MZ, S ̧ahin F. Nosocomial urinary tract infections in a university hospital: Causative microorganisms and antimicrobial resistance. Cumhuriyet Universitesi Ti{dotless}p Fakultesi Dergisi 2003; 25: 63-8.
30. Demirci M, Aridoǧan BC, Arda M. Antibiotic sensitivity of gram negative bacilli isolated from outpatients urine cultures. ANKEM Derg 2000; 14: 576-9.
31. Taşova Y, Saltoǧlu N, Yaman A, Yilmaz G, Dundar IH. Nosocomial urinary tract infections in the Medical Faculty Hospital, Cukurova University. Turkish J Infect 1999; 13: 249-254.
32. Erdem H, Avci A, Pahsa A. Th e Antibacterial resistance in community acquired uropathogenic Escherichia coli strains. ANKEM Derg 2004; 18: 40-4.
33. Akan OA. Antibiotic Resistance of urinary Escherichia coli isolated from outpatient samples against fi rst line drugs. Ankara Universitesi Ti{dotless}p Fakultesi Mecmuasi{dotless} 2003; 56: 147-50.
34. Sucu N, Boz GA, Bayraktar O, Caylan R, Aydin K, Koksal I. Th e change of antibiotic susceptibilities of uropathogen Escherichia coli strains in years. Klimik Dergisi 2004; 17: 128-131.
35. Tolun V, Akbulut DT, Catal C, Turan N, Kucuker MA, Ang O. Th e antibiotic susceptibilities of gram negative rods isolated as causative agents of urinary tract infections from in- and outpatients. Turk Mikrobiyol Cem Derg 2002: 32: 69-74.
36. Eroǧlu C, Gunaydin M, Birinci A, Esen Ş, Sunbul M, Leblebicioǧlu H. determination of extended spectrum beta lactamases (ESBL) in Escherichia coli strains isolated from urinary system infections. Turk Mikrobiyol Cem Derg 2003; 33: 118-121.
37. Kibar F, Yaman A, Dundar IH. Bacteria isolated from urine samples and their antibiotic susceptibilities. Turk Mikrobiyol Cem Derg 2004; 34: 162-170.
38. Citil BE, Coplu N, Gozalan A, Oncul O, Karaca Y, Esen B. The evaluation of antibiotic resistance in urinary tract infection agent Enterobacteriaceae spp. for two years. Th e Medical Journal of Kocatepe 2006; 7: 31-5.
39. Şencan I, Sevinc ME. Antimicrobial resistance survey of community-acquired uropathogen Escherichia coli isolated. Klimik Dergisi 2002; 15: 85-8.
40. Altindiş M, Tanir HM. Microbiological evaluation of urine samples taken from patients with urinary tract infections symptoms and susceptibilities to various antibiotic against of the gram-negative microorganisms isolated from those women. Turk Microbiyol Cem Derg 2001; 31: 192-7.
41. Savaş L, Guvel S, Turunc T, Savaş N, Arslan H. Comparison of the causative microorganisms and their antibiotic susceptibility between community acquired and nosocomial urinary tract infections. Turk Uroloji Dergisi 2003; 29: 95-100.
42. Ertuǧrul MB, Gulec LA, Akal D, Cagatay AA, Ozsut H, Eraksoy H, Calangu S. Susceptibility of uropathogen Escherichia coli isolates to the antimicrobials used commonly in urinary tract infections. Klimik Dergisi 2004; 17: 132-6.
43. Tunger O, Surucuoǧlu S, Ozbakkaloǧlu B, Gazi H. Extended spectrum beta lactamase production and susceptibility to antibiotics in Escherichia coli strains isolated from community acquired and nosocomial infections. Mikrobiyol Bult 2001; 35: 351-357.
44. Pullukcu H, Aydemir Ş, Taşbakan MI, Sipahi OR, Cilli F, Ulusoy S. In vitro effi cacy of nitrofurantoin Escherichia coli strains isolated from urine cultures. Turk J Infect 2007; 21: 197-200.
45. Gazi H, Surucuoǧlu S, Kurutepe S. Antimicrobial resistance of Gram Negative bacteria isolated from urine cultures. ANKEM Derg 2007; 21: 19-22.
46. Kocoǧlu E, Karabay O, Ince NK, Ozkardeş F, Yildirim R. The frequency of extended spectrum beta-lactamase production and antibiotic susceptibility of Escherichia coli strains isolated from community-acquired urinary tract infections. ANKEM Derg 2007; 21: 5-9.
47. Turunc T, Turunc T. Nosocomial urinary tract infections related with urinary catheter in patients from intensive care units. Turk Uroloji Dergisi 2003; 29: 209-14.
48. Ay S, Işeri LA, Duman B. Antibiotic Susceptibilities of Gram Negative microorganisms isolated from urine samples. Inonu Universitesi Ti{dotless}p Fakultesi Dergisi 2003; 10: 59-62.
49. Şahin I, Oksuzş, Kaya D, Şencan I, Gulcan A. Antibiotic susceptibility of uropathogenic Gram Negative rods isolated from inpatient and outpatient children. ANKEM Derg 2004; 18: 101-104.
50. Yetkin G, Kuzucu C, Calişkan A. An investigation on Escherichia coli strains with extended spectrum beta lactamase growth in urinary cultures. Inonu Universitesi Ti{dotless}p Fakultesi Dergisi 2006; 13: 249-252.
51. Arca AE, Karabiber N. Short Communication: Comparison of susceptibilities of Escherichia coli urinary tract isolates against fosfomycin tromethamine and diff erent antibiotics. Microbiyol Bult 2007; 41: 115-119.
52. Gulsun S, Oǧuzoǧlu N, Ceran N, Inan A, Goktaş P. The virulence factors and antibiotic sensitivities of Escherichia coli strains isolated from recurrent urinary tract infections. Saudi Med J 2005; 26: 1755-8.
53. Oktem MA, Gulay Z, Ercan H, Bicmen M, Yuluǧ N. Microorganisms isolated in intensive care units and their antibiotic susceptibility. Turk J Infect 2001; 15: 61-66.
54. Timurkaynak F, Inci EK, Arslan H. Characteristics and antibiotic susceptibility of pathogens isolated from community acquired and nosocomial urinary tract infections. Ankara Universitesi Ti{dotless}p Fakultesi Mecmuasi{dotless} 2001; 54: 287-292.
55. Aral M, Ciragil P, Gul M, Ekerbicer HC, Celik M, Kocturk SA. The spectrum of bacteria isolated from urinary tract infections in children aged 0-5 years and antibiotic resistance status of Gram Negative bacteria. Kahramanmaraş Sutcu Imam Universitesi Ti{dotless}p Fakultesi 2005; 2: 5-9.
56. Şener A, Yapar N, Cakir N, Yuce A. Searching asymptomatic bacteriuria in Yeşilyurt nursery home geriatric residents and susceptibility patterns of bacteriae. Medical Journal of Izmir Hospital 2004; 10: 69-71.
57. Sumer Z, Coşkunkan C, Vahaboglu H, Bakir M. Th e resistance of Escherichia coli strains isolated from community-acquired urinary tract infections. Adv Th er 2005; 22: 419-23.
58. Ozyurt M, Haznedaroǧlu T, Sahiner F, Oncul O, Ceylan S, Ardic N, Erdemoǧlu A. Antimicrobial resistance profi les of community-acquired uropathogenic Escherichia coli isolates during 2004-2006 in a training hospital in Istanbul Mikrobiyol Bul 2008; 42: 231-43.
59. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999; 29: 745-758.
60. Puerto AS, Fernandez JG, del Castillo Jde D, Pino MJ, Angulo GP. In vitro activity of beta-lactam and non-beta-lactam antibiotics in extended-spectrum beta-lactamase-producing clinical isolates of Escherichia coli. Diagn Microbiol Infect Dis 2006; 54: 135-9.
61. Alhambra A, Cuadrs JA, Cacho J, Gomez-Garces JL, Alos JI. In vitro susceptibility of recent antibiotic-resistant urinary pathogens to ertapenem and 12 other antibiotics. J Antimicrob Chemother 2004; 53: 1090-4.
62. Hernandez JR, Martinez-Martinez L, Canton R, Coque TM, Pascual A. Spanish Group for Nosocomial Infections (GEIH). Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases in Spain. Antimicrob Agents Chemother. 2005; 49: 2122-5.
63. Kamberovic SU. Antibiotic resistance of coliform organisms from community-acquired urinary tract infections in Zenica-Doboj Canton, Bosnia and Herzegovina. JAC 2006; 58: 344-8.
64. Andrade SS, Sader HS, Jones RN, Pereira AS, Pignatari AC, Gales AC. Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: time for local guidelines? Mem Inst Oswaldo Cruz. 2006; 101: 741-8.
65. Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India. Ann Clin Microbiol Antimicrob 2007; 6: 4.
66. Canbaz S, Peksen Y, Tevfik Sunter A, Leblebicioglu H, Sunbul M. Antibiotic prescribing and urinary tract infection. Int J Antimicrob Agents. 2002; 20: 407-11.
67. Nordmann P, Poirel L. Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J Antimicrob Chemother 2005; 56: 463-9.
68. Marchese A, Gualco L, Debbia EA, Schito GC, Schito AM. In vitro activity of fosfomycin against gram-negative urinary pathogens and the biological cost of fosfomycin resistance. Int J Antimicrob Agents. 2003; 22 Suppl 2: 53-59
69. Das RN, Chandrashekhar TS, Joshi HS, Gurung M, Shrestha N, Shivananda PG. Frequency and susceptibility profi le of pathogens causing urinary tract infections at a tertiary care hospital in western Nepal. Singapore Med J. 2006; 47: 281-5.
70. Gobernado M, Valdes L, Alos JI, Garcia-Rey C, Dal-Re R, Garcia-de-Lomas J;Spanish Surveillance Group for Urinary Pathogens. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain. Rev Esp Quimioter 2007; 20: 68-76.
71. Farrell DJ, Morrissey I, De Rubeis D, Robbins M, Felmingham D. AUK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J Infect 2003; 46: 94-100.
72. Tasbakan M, Pullukcu H, Sipahi O, Yamazhan T, Ulusoy S. Nitrofurantoin In the treatment of Extended-Spectrum Beta-Lactamase (ESBL) Producing E. coli related lower urinary tract infection (luti). 48th Interscience Conference on Antimicrobial Agents and Chemotherapy, 46th Infectious Diseases Society of America Annual Meeting. Washington, poster L494.
73. Sipahi OR. Economics of antibiotic resistance. Exp Rev Anti-Infect Ther 2008; 6: 523-539.
74. Talan DA, Krishnadasan A, Abrahamian FM, Stamm WE, Moran GJ. EMERGEncy ID NET Study Group. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fl uoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis. Clin Infect Dis 2008; 47:1150-8.
75. Guajardo-Lara CE, Gonzalez-Martinez PM, Ayala-Gaytan JJ. Antibiotic resistance of Escherichia coli from communityacquired urinary tract infections. What antimicrobial to use? Salud Publica Mex. 2009; 51: 155-9.
76. Ungheri D, Albini E, Belluco G. In-vitro susceptibility of quinolone-resistant clinical isolates of Escherichia coli to fosfomycin trometamol. J Chemother. 2002; 14: 237-40.
77. Pullukcu H, Tasbakan M, Sipahi OR, Yamazhan T, Aydemirş, Ulusoy S. Fosfomycin in the treatment of extended spectrumbeta-lactamase-producing Escherichia coli-related lower urinary tract infections. Int J Antimicrob Agents 2007; 29: 62-65.